Eberwine et al. 10 measured the expression of a handful of individual genes from single cells for the first time in 1992, using a sophisticated approach based on in vivo reverse transcription (RT) followed by amplification through IVT. Later, simpler, PCRbased methods emerged 11 that led to scaling up of the number of cells and genes assayed over the years 12, 13 . Eventually, untargeted single-cell mRNA (or cDNA) amplification techniques were developed, which allowed researchers to perform transcriptomewide studies using microarrays [14] [15] [16] [17] . Building upon this, Tang et al. adapted the technologies to make them compatible with highthroughput DNA sequencing, thus allowing completely unbiased transcriptome-wide investigation of the mRNA in a single cell for the first time 18 .
Early single-cell experiments were motivated by the prospect of an in-depth analysis of gene expression in a few precious cells [18] [19] [20] [21] [22] . A shift in the field came when Guo et al. demonstrated that distinct cell types could be identified without pre-sorting: the authors carried out RT-qPCR of 48 genes in parallel on more than 500 cells 23 , demonstrating the utility of measuring larger numbers of cells. This inspired the Linnarsson group 24 to develop methods explicitly targeted at assaying many cells in parallel via multiplexed unbiased RNA-seq, with the long-term goal of eventually cataloging all neuronal cell types 25, 26 .
In the past few years, many sensitive and accurate singlecell RNA-sequencing (scRNA-seq) protocols have been introduced 27 . Here we focus on the increase in the number of cells profiled per study, a key factor in the ability to catalog cell types. We review the exponential growth of scale in single-cell transcriptomics experiments, from tens of cells up to hundreds of thousands of single cells per study in less than a decade, and discuss the technological advances that have enabled this ( Fig. 1,  Supplementary Table 1 ).
Many different incremental improvements have contributed to increases in scale, such as, for example, decreases in required Many biological discoveries have been made possible by the development of new methods and technological progress. For example, the improvements made to microscopes in the 17th century allowed Robert Hooke and Anton van Leeuwenhoek to describe the cell as the structural unit of life for the very first time 1 . Since then, many studies have focused on cell characterization, redefining the cell as not only the structural but also the functional unit of life 2 .
Cells have traditionally been classified according to their morphology or the expression patterns of certain proteins in functionally distinct settings [3] [4] [5] . Changes in cellular activity and identity are reflections of distinct gene expression programs 6, 7 . Proteomic technologies have the advantage of assaying the final functional product of gene expression, but at the single-cell level, proteomics assays are constrained to a limited, pre-selected repertoire of molecules, which precludes an unbiased, comprehensive analysis of cell phenotypes. Assay of the transcriptome (the abundance of all transcribed RNAs) in a single cell with methodologies such as RNA-seq provides an alternative means to classify and characterize cells at the molecular level 8, 9 .
All single-cell RNA-seq protocols share a common initial step in which transcribed RNA from cells is converted to cDNA. The next step is an amplification by molecular biology methods such as polymerase chain reaction (PCR) and in vitro transcription (IVT). The subsequent steps, culminating in sequencing, allow the expression level of gene products to be quantified.
Exponential scaling of single-cell RNA-seq in the past decade
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Measurement of the transcriptomes of single cells has been feasible for only a few years, but it has become an extremely popular assay. While many types of analysis can be carried out and various questions can be answered by single-cell RNA-seq, a central focus is the ability to survey the diversity of cell types in a sample. Unbiased and reproducible cataloging of gene expression patterns in distinct cell types requires large numbers of cells. Technological developments and protocol improvements have fueled consistent and exponential increases in the number of cells that can be studied in single-cell RNA-seq analyses. In this Perspective, we highlight the key technological developments that have enabled this growth in the data obtained from single-cell RNA-seq experiments. each requiring different strategies for adaptor addition. PCR amplification requires the addition of adaptor sequences at both ends of the double-stranded cDNA. Most techniques use the poly(A) tail of the mRNA to generate the first strand of cDNA, by initiating RT using a poly(T)-oligonucleotide that also contains a universal adaptor sequence. The second adaptor can then be incorporated during the cDNA-amplification step via several different strategies. In the homopolymer tailing approach, a transferase adds a poly(A) tail to the 3′ end of the first-strand cDNA. Subsequently, a poly(T) primer with a different universal anchor is incorporated into the second strand. The two different adaptor sequences are then used for PCR amplification. This protocol was first applied to single-cell analysis in 2002 (ref. 30) and eventually was adapted for use with microarrays 15, 16 and scRNA-seq 18 . Although long cDNAs have been transcribed by this approach 18 , a drawback of the method is the reduction of 5′ transcript coverage owing to premature termination of the RT. Template-switching PCR is an alternative strategy that ensures the full transcription of the RNA. This method is based on the intrinsic ability of the transcriptases of the Moloney murine leukemia virus to add a small number of nucleotides (mostly cytosines) when the RT reaches the end of the mRNA 31 . The addition of a helper oligonucleotide containing complementary nucleotides and the second adaptor allows the polymerase to automatically initiate second-strand synthesis without requiring homopolymer tailing. In the single-cell tagged reversetranscription sequencing (STRT-seq) method 24 , full-length cDNA is amplified by template switching, but only the 5′-end fragment reagent volumes and consumable costs 9,28 facilitated by the introduction of microfluidic technologies, random capture methods and in situ barcoding (Fig. 1a) . In this Perspective we focus on solutions for three key challenges: untargeted amplification of whole transcriptomes from single cells, automatic isolation of cells and the ability to process many cells in parallel.
Untargeted amplification of whole transcriptomes from single cells
For successful signal detection with RNA-seq, on the order of 0.1-1.0 µg of total RNA is needed (see, for example, information from the Truseq and NEBNext kits: https://support.illumina. com/sequencing/sequencing_kits/truseq_rna_sample_prep_kit/ input_req.html; https://www.neb.com/faqs/2012/11/19/what-isthe-starting-material-i-need-to-use-when-preparing-librariesusing-the-nebnext-ultra-dire). The amount of RNA present in a single cell is limited, and ranges from 1-50 pg depending on cell type 29 . One way to overcome this problem is to convert RNA from a single cell into cDNA and amplify it before a sequencing library is created. (DNA-sequencing kits typically require on the order of 1 ng of DNA; see, for example, https://support.illumina. com/sequencing/sequencing_kits/nextera_xt_dna_kit/input_req. html). For this to be achieved, adaptor sequences need to be added to all mRNA transcripts. Delivery of these adaptors without prespecification of target sequences of particular genes was the main technical challenge in early single-cell RNA studies.
Amplification of cDNA can be exponential, by PCR amplification, or linear, via multiple rounds of IVT, with A jump to ~100 cells was enabled by sample multiplexing, and then a jump to ~1,000 cells was achieved by large-scale studies using integrated fluidic circuits, followed by a jump to several thousands of cells with liquid-handling robotics. Further orders-of-magnitude increases bringing the number of cells assayed into the tens of thousands were enabled by random capture technologies using nanodroplets and picowell technologies. Recent studies have used in situ barcoding to inexpensively reach the next order of magnitude of hundreds of thousands of cells. More recently, methods emerged to randomly capture and manipulate individual cells in nanoliter droplet emulsions 40 . The inDrop and Drop-seq protocols both present strategies to isolate cells in droplets and carry out barcoded cDNA preparation within each droplet 34, 41 . Here, two flows of liquidone containing reagents (including lysis buffer and reverse transcriptase) and beads with poly(T) RT primers, and the other containing cells in buffer-are merged into a combined flow. This flow is separated into droplets by the addition of oil at set intervals. By calibrating the relative rate of the two flows and controlling the creation of droplets, a user can ensure that in most cases only single cells will be isolated in droplets by Poisson statistics. Because of the random nature of this process, it requires a large number of cells and thus is not suited to samples with limited availability of cells.
In an alternative strategy, cells can be deposited at random into picoliter wells that contain barcoded beads and reagents 35, 42, 43 . The same beads as for droplet protocols can be used to deliver RT primers into individual wells, but no pumps or other microfluidic equipment is needed. Instead, cells are isolated into the picoliter wells by gravity. Each plate has an upper limit of cells determined by the number of wells, and Poisson statistics are used to calculate the limiting dilution required to avoid doublets, resulting in only a small fraction of the wells containing a single cell.
Barcoding strategies for efficient multiplexing
"Multiplexing" refers to the practice of processing and analyzing multiple samples at once. In sequencing assays this is achieved through the addition of molecular barcodes to cDNA fragments. This way, material from many cells can be pooled, which allows subsequent steps to be performed in a single tube. When the multiplexing step is performed early in the workflow, the amount of labor and material needed to create a sequencing library is dramatically reduced. It also enables the use of technologies that require a minimal input level of material, such as IVT 44 . Furthermore, libraries from many cells can be sequenced together to spread the sequencing read depth over many cells.
Islam et al. published the first single-cell RNA-seq protocol for multiplexing cells from a single 96-well plate by using a unique template-switching oligo (TSO) in each well via their STRT-seq method 24 (a later version of STRT-seq removed early multiplexing in favor of passive cell capture with the Fluidigm C1 platform). In early multiplexing strategies, a unique barcode for each isolated cell was incorporated into the cDNA fragments before library generation, in either the TSO 24 or the RT adaptor 41, 44, 45 , or during full-length PCR 46 .
Furthermore, different multiplexing approaches can be combined through the use of multiple barcoding steps. In MARSseq, a variant of the CEL-seq protocol, an additional barcode is added during library preparation to increase the number of cells that can be sequenced in parallel. A similar strategy was introduced in the STRT-Seq-2i protocol 46 -here up to 100 barcodes are added during full-length PCR, followed by 96 additional barcodes for different regions of their array during library preparation, allowing a total of 9,600 cells to be multiplexed and sequenced together.
is captured and sequenced. By contrast, fragments from the fulllength cDNA are sequenced in the SMART-seq method 21 .
The second option, IVT, is the approach that was originally used to pioneer single-cell analysis of the transcriptome 10 . The CEL-seq (cell expression by linear amplification and sequencing) protocol leveraged this for linear mRNA amplification from single cells. Here the RT adaptor also contains a T7 promoter sequence, which allows the final double-stranded DNA to be transcribed into multiple copies of antisense RNA 32 . Once enough amplified antisense RNA has been produced, it can be fragmented and again reverse-transcribed to cDNA. This method was also used for MARS-seq (massively parallel scRNA-seq) 33 , and later for InDrop (droplet sequencing) 34 and Seq-Well (a well-array-based variation on MARS-seq) 35 .
Simplified, automated cell isolation
The earliest single-cell experiments analyzed only a handful of cells that were each manually isolated in single tubes before RNA was extracted via cell lysis. With improvements in the methodology, larger numbers of cells could be analyzed in parallel, and microtiter plates were used for the new methods. Although some devices such as custom-built semiautomatic cell pickers 24 were designed, an easy-to-implement alternative was to use fluorescence-activated cell sorting (FACS) to isolate cells into microwell plates.
FACS has frequently been used to increase the scale of singlecell sequencing. Some methods have used specialized adaptations of FACS: the MASC-seq method makes use of a spatially barcoded poly(dT) array which cells are sorted onto 36 . The recently published nanoliter-volume microwell array platform used for the STRT-seq-2i protocol also takes advantage of FACS to load cells into miniscule wells in custom capture plates.
A further increase in scale was achieved through robotic automation after cell capture 33, 37 . However, specialized flow cytometers are expensive and require dedicated staff. Different forms of passive and random cell-capture technologies were developed to reduce the need for such instrumentation.
The first commercial tool for passive cell capture for scRNAseq was the microfluidic C1 system released by Fluidigm. The company had expertise in producing systems for parallel RT-qPCR (https://www.fluidigm.com/about/aboutfluidigm) in single cells, and adapted the technology for sequencing. The key feature of the Fluidigm technology is the design of microfluidics devices (or chips) that allow the sequential delivery of very small and precise volumes into tiny reaction chambers. Cells are loaded onto the chip and are passively captured in (up to) 96 isolated chambers in about half an hour. Several steps of the SMART-seq protocol can be carried out within the chambers of the chip before cDNA is extracted from the chip and deposited in microwell plates for the generation of a sequencing library. Complex single-use integrated fluidic circuit (IFC) chips are fundamentally limited to a set number of chambers for capturing cells (96 in the current version), and in many cases only a fraction of the chambers successfully capture cells, depending on the cell type 25, 38 . Some large-scale studies made use of a large number of IFCs to create big data sets 25, 39 . cells by FACS, distributed over multiwell plates with unique barcodes in each well. First-strand synthesis labels all cells in the well with a first barcode. Cells are then pooled and again randomly split into mini-pools in plate wells by FACS, and a second well-specific barcode is then added. This procedure can be repeated ad infinitum before final pooling of the cells to amplify the material and create a sequencing library. This results in an arbitrarily low probability that any two cells will co-locate in the same sequence of wells, and so RNA from each cell is uniquely labeled.
Unlike in isolation-based methods, the number of potential labeled cells in an experiment can be exponentially scaled through increasing numbers of barcoding rounds. This technology was also reported to be compatible with single-nucleus sequencing 52 . Developments such as this hold the promise of enabling very large studies in the future, such as the cataloging of Caenorhabditis elegans cells described in ref. 51 .
Current limitations and future directions
The isolation and handling of individual cells have become much simpler in recent years. However, a remaining limitation is the requirement for large volumes of cell suspensions. Using the earlier, labor-intensive manual isolation methods, one can ensure that as much cellular material as possible is used, but when cells are automatically and randomly isolated in droplets or wells, only a fraction of the cells in the suspension will be captured. (In principle one can overcome this by massively expanding the pool of barcoded beads and decreasing the cell capture speed, but this entails significant increases in cost.)
For certain tissues it can also be difficult to make singlecell suspensions, and storage of cell suspensions or tissues can sometimes prove challenging. Recent work has proposed moving to sequencing of individual nuclei to simplify the creation of suspensions, as nuclei can be extracted from tissues (including frozen or fixed samples) by Dounce homogenization followed by purification to create a clean suspension, with positive results 46, [53] [54] [55] .
The cost of sequencing is also still prohibitive for studies that involve hundreds of thousands of cells, even at low sequencing depths. The new Illumina NovaSeq 6000 sequencing instrument promises a 45% reduction in sequencing cost for large studies (https://www.illumina.com/systems/sequencing-platforms/ novaseq.html), but a radical change in sequencing technology might be needed to bring costs down further.
An important aspect of the cellular heterogeneity of tissues is the spatial context of cells 56 . When a suspension of cells is created, information about this is lost. Recently, a method based on CELseq was created to retain the spatial location of mRNA expression in thin tissue slices 57 , although not with single-cell resolution. Other methods based on single-molecule fluorescent in situ hybridization have been scaled up to measure the expression of up to 1,000 predefined target genes in tens of thousands of single cells by imaging [58] [59] [60] . Recent promising work has shown untargeted sequencing of cDNA from mRNA inside cells via the fluorescent in situ sequencing method 61, 62 . The ability to also investigate the spatial context of gene expression with single-cell RNA-seq will Early multiplexing is critical for random cell-isolation methods because no reagents can be added to the individual cell lysates after the cells have been captured. To allow labeling of cDNA from cells isolated in individual droplets (or picoliter wells), the beads with RT primers also contain a barcode. RT and barcoding can therefore happen in each individual isolate. After this, material can be treated as in other protocols. For example, InDrop uses the same IVT protocol as CEL-seq on the barcoded material 34 , whereas, for example, Drop-seq and Seq-Well use PCR-based methods for multiplexed amplification of barcoded cDNA 35, 41 .
To increase the number of cells that can be multiplexed, a greater number of barcodes is required, which necessitates the use of longer oligos at prohibitive synthesis costs. This can be avoided by two different strategies: the combination of multiple shorter designed barcodes (e.g., 8-10 bases) into longer barcodes (e.g., 8 bases + 22-base linker + 10 bases = 40 bases), or the synthesis of very long (e.g., 12 bases) random barcodes.
The first, combinatorial approach was first described with the targeted CytoSeq method. The authors used initial pools of 96 barcodes into which beads were split-pooled three times to generate a set of 96 3 = 884,736 barcoded beads 42 . A similar method called 'mix & expand' was later published by which the authors created 96 2 = 9,216 barcoded beads 43 . Similarly, the InDrop method was used to barcode hydrogel beads through combinatorial ligation of two sets of 384 barcodes, creating 384 2 = 147,456 unique barcoded beads 34 . This approach is used by the commercial Illumina SureCell system, with 96 3 = 884,736 unique beads (https://support.illumina.com/sequencing/sequencing_kits/ surecell-wta-3-kit.html).
The second approach was taken in the Drop-seq and Seq-Well protocols, where the authors used 12 rounds of split-pool singlebase DNA synthesis on the beads to generate 4 12 = 16.7 million barcodes 35, 41 . This procedure is simpler than the first approach, and does not require any synthesized oligos for the barcodes. However, in the first approach barcodes can be designed to avoid biases 47 and ensure that barcode sequences will be distinct. In order for potential barcode collisions to be avoided, randomly synthesized barcodes need to be longer, which decreases the probability that similar barcodes will get assigned to droplets with cells in them.
The Poisson statistics of cell capture needed to ensure that mostly single cells are isolated during random cell-isolation methods means there will always be large inefficiencies in terms of cell isolation, and the pool of barcodes will always have to be substantially larger than the number of cells captured to avoid barcode duplication. A remarkable strategy that allows a user to avoid both of these pitfalls is combinatorial in situ barcoding. This technique was initially devised for single-cell assay for transposase-accessible chromatin using sequencing (scATACseq) 48 and later was adapted for whole-genome sequencing 49 and single-cell Hi-C 50 . Recently, these concepts were adapted to scRNA-seq in the single-cell combinatorial-indexing RNAseq 51 and split-pool ligation-based transcriptome sequencing 52 methods. Here single cells are never individually isolated and lysed; instead, cells are fixed and the mRNA is manipulated in situ inside each cell. Cells are split into mini-pools of ~10-100 enable scientists to understand cellular heterogeneity, identify genes important for tissue structure 63 and form a technology complementary to highly multiplexed sequencing of cell suspensions.
Conclusion
In this Perspective we have discussed the scaling up of RNA-seq experiments over the past decade, which has permitted a shift from the study of individual or small numbers of cells to the study of whole organisms and their cell-type compositions. It is now standard practice for published papers to investigate tens of thousands of cells from a number of experimental systems or tissues, with the largest studies consisting of hundreds of thousands of cells. Thanks to these advances in scRNA-seq technology, researchers are taking steps toward more fully understanding what people are made of, by reproducibly cataloging the diversity of cell types and gene expression patterns within them.
